Philips has launched a cloud-based version of its IntelliSite Pathology Solution on AWS, enabling labs to scale digital workflows and manage high-resolution pathology images without on-premise infrastructure, according to the company.
A University of Warwick study finds AI cancer detection models may rely on statistical correlations rather than true biomarker signals, raising concerns about reliability in clinical pathology applications.
A Duke-led study reports that measuring piRNAs in blood samples predicts two-year survival in older adults with up to 86% accuracy, outperforming traditional health indicators, according to findings published in Aging Cell.
The AI companion analyzes up to five years of personal lab data within the company's patient portal to explain test results and identify health trends.
Utah State researchers have identified new CRISPR-Cas12a3 functions that selectively target pathogen RNA without harming host DNA, potentially enabling a single diagnostic test for COVID-19, flu, and RSVV..
